Beijing Tongrentang Co Ltd
SSE:600085
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
31.21
54.9
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Beijing Tongrentang Co Ltd stock under the Base Case scenario is 58.08 CNY. Compared to the current market price of 39.53 CNY, Beijing Tongrentang Co Ltd is Undervalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Beijing Tongrentang Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Beijing Tongrentang Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Beijing Tongrentang Co Ltd
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Beijing Tongrentang Co Ltd, a name synonymous with traditional Chinese medicine, has a storied history dating back to 1669. Founded during the Qing Dynasty, the company has earned a reputation as one of China's premier producers of herbal medicines and health products. Tongrentang's core offerings include a diverse array of traditional remedies, pharmaceuticals, and health supplements, all rooted in the principles of Chinese medicine. The company's commitment to quality and authenticity is underscored by its rigorous sourcing of natural ingredients and adherence to ancestral recipes, making it a trusted brand among consumers in China and increasingly globally. As investors look for opportuni...
Beijing Tongrentang Co Ltd, a name synonymous with traditional Chinese medicine, has a storied history dating back to 1669. Founded during the Qing Dynasty, the company has earned a reputation as one of China's premier producers of herbal medicines and health products. Tongrentang's core offerings include a diverse array of traditional remedies, pharmaceuticals, and health supplements, all rooted in the principles of Chinese medicine. The company's commitment to quality and authenticity is underscored by its rigorous sourcing of natural ingredients and adherence to ancestral recipes, making it a trusted brand among consumers in China and increasingly globally. As investors look for opportunities in the growing health and wellness sector, Tongrentang stands out as a pioneer integrating time-honored practices with modern production standards.
In recent years, Beijing Tongrentang has strategically embraced innovation and expansion, aligning its operations with the rising trend of holistic health and preventive medicine. With a robust distribution network that spans both physical retail and e-commerce, the company is progressively reaching a broader audience, particularly among health-conscious consumers in urban areas. Its focus on international markets is particularly compelling, as it seeks to capitalize on the global interest in alternative medicine and wellness. For investors, Tongrentang not only represents a stable, dividend-generating company with deep cultural roots but also an opportunity to enter a burgeoning market where traditional wisdom meets contemporary health trends. As the world increasingly shifts towards integrative health solutions, Beijing Tongrentang's legacy and ongoing evolution present a unique proposition for discerning investors.
Beijing Tongrentang Co., Ltd. is a well-known traditional Chinese medicine (TCM) company with a history dating back to 1669. Its core business segments can be categorized as follows:
-
Traditional Chinese Medicine Products:
- This segment focuses on the research, development, production, and distribution of a wide range of traditional Chinese herbal medicines, including herbal remedies, patent medicines, and specific formulations for various health conditions. This is the company's primary business area and reflects its heritage.
-
Health Food and Supplements:
- Tongrentang also offers a variety of health food products, dietary supplements, and functional foods that incorporate traditional Chinese medicinal principles. These products aim to enhance general well-being and are marketed to health-conscious consumers.
-
Medical Services:
- The company has expanded into the realm of medical services, offering outpatient services that cater to patients seeking TCM treatments. This includes clinics and wellness centers where traditional practices such as acupuncture, massage therapy, and dietary consultation are provided.
-
International Business:
- With an aim to promote traditional Chinese medicine globally, Beijing Tongrentang has invested in international markets. This segment focuses on establishing overseas retail outlets, collaborations, and partnerships to sell TCM products to a global audience.
-
E-commerce and Retail:
- The company operates both brick-and-mortar stores and an e-commerce platform to reach consumers. This segment has grown especially in recent years, leveraging digital channels to expand its market presence.
-
Research and Development:
- Continuous research and development in TCM is vital for Tongrentang. This segment emphasizes innovation and quality control, ensuring that their products meet modern regulatory standards while maintaining the efficacy of traditional formulations.
Together, these core business segments reflect Beijing Tongrentang's commitment to preserving the principles of traditional Chinese medicine while adapting to contemporary health trends and market demands.
Beijing Tongrentang Co., Ltd., a prominent player in the traditional Chinese medicine sector, possesses several unique competitive advantages that distinguish it from its rivals:
-
Brand Heritage and Reputation: Founded in 1669, Tongrentang has a rich history and a well-established brand. Its long-standing reputation for quality and authenticity in traditional Chinese medicine (TCM) provides consumer trust that newer entrants may struggle to achieve.
-
Quality Assurance and Standards: The company emphasizes rigorous quality control in the production of its herbal products. It adheres to both national and international quality standards, which enhances its credibility over competitors who may not maintain the same production rigor.
-
Comprehensive Distribution Network: Tongrentang has built a vast and sophisticated distribution network, including pharmacies, hospitals, and online channels. This extensive reach allows it to effectively serve a diverse customer base.
-
Sourcing of Raw Materials: The company has established relationships with reliable sources of high-quality herbal ingredients. This ensures consistent product quality and availability, a critical factor in maintaining customer loyalty.
-
Research and Development: Tongrentang invests significantly in R&D to innovate and improve its product offerings. This commitment to developing new products that blend traditional practices with modern science gives it a competitive edge in a rapidly evolving market.
-
Global Expansion Strategy: With a focus on international markets, Tongrentang is actively expanding its presence beyond China. Its early movement into markets with growing interest in TCM allows it to capture new customer segments before local competition intensifies.
-
Regulatory Compliance and Certifications: The company is well-versed in navigating the regulatory landscape, having obtained essential certifications (such as Good Manufacturing Practices). This compliance not only reassures customers of product safety but also sets it apart from less compliant competitors.
-
Integrated Business Model: Tongrentang’s vertical integration—from herb procurement to production and retail—allows for greater control over the entire process, leading to higher efficiency, consistency, and cost-effectiveness.
-
Consumer Education and Promotion: The company actively educates consumers about TCM's benefits, positioning itself as a thought leader in the field. This strategy not only fosters brand loyalty but also cultivates a deeper understanding of the efficacy of its products among consumers.
-
Customization and Personalization: Tongrentang offers personalized herbal remedies and services, which may be tailored to individual needs. This focus on customized solutions enhances customer satisfaction and loyalty compared to more generic offerings from rivals.
By leveraging these competitive advantages, Beijing Tongrentang Co., Ltd. not only strengthens its market position but also sets a robust foundation for future growth amid increasing competition in the health and wellness industries.
Beijing Tongrentang Co., Ltd., a well-known brand in traditional Chinese medicine (TCM), faces several risks and challenges in the near future:
-
Regulatory Risks: The global regulatory environment for herbal and traditional medicine is evolving, which may lead to stricter regulations. Compliance with new guidelines can increase operational costs and affect marketability.
-
Competition: The TCM market is becoming increasingly competitive, not only from domestic companies but also from international firms entering the space. The emergence of new products and services could impact Tongrentang's market share.
-
Supply Chain Disruptions: As seen in recent years, global supply chains can be disrupted due to various factors, including geopolitical tensions, natural disasters, or pandemics. Such disruptions may affect the availability and cost of raw materials essential for TCM production.
-
Changing Consumer Preferences: There is a growing trend towards modern medicine and alternative therapies. If consumer preferences shift away from traditional remedies, Tongrentang may need to adapt its product offerings.
-
Intellectual Property Issues: The herbal medicine industry is susceptible to issues related to intellectual property rights, including patent disputes and potential infringement on traditional knowledge.
-
Economic Factors: Economic fluctuations, such as recession or inflation, can influence consumer spending on healthcare products, impacting sales.
-
Market Saturation: With the proliferation of TCM brands and products, certain markets may become saturated, leading to decreased profits and increased marketing costs.
-
International Market Penetration: Expanding into international markets presents both opportunities and challenges. Understanding local regulations, consumer behavior, and competition is crucial for successful globalization.
-
Digital Transformation and E-commerce: As e-commerce continues to grow, Tongrentang must invest in digital marketing and distribution channels. Failure to keep pace with technology trends can hinder growth potential.
-
Environmental Sustainability: Increasing awareness and concern regarding sustainability can affect sourcing strategies and may require changes to production processes to meet consumer and regulatory expectations.
Navigating these risks will require strategic planning, investment in innovation, and a thorough understanding of both the domestic and international market landscape.
Revenue & Expenses Breakdown
Beijing Tongrentang Co Ltd
Balance Sheet Decomposition
Beijing Tongrentang Co Ltd
Current Assets | 24.3B |
Cash & Short-Term Investments | 11.4B |
Receivables | 2.1B |
Other Current Assets | 10.7B |
Non-Current Assets | 7.1B |
Long-Term Investments | 83.6m |
PP&E | 5.8B |
Intangibles | 816.7m |
Other Non-Current Assets | 382m |
Current Liabilities | 7.3B |
Accounts Payable | 3.9B |
Accrued Liabilities | 747.3m |
Short-Term Debt | 822.4m |
Other Current Liabilities | 1.9B |
Non-Current Liabilities | 10.7B |
Long-Term Debt | 3B |
Other Non-Current Liabilities | 7.7B |
Earnings Waterfall
Beijing Tongrentang Co Ltd
Revenue
|
18B
CNY
|
Cost of Revenue
|
-10B
CNY
|
Gross Profit
|
8B
CNY
|
Operating Expenses
|
-5.2B
CNY
|
Operating Income
|
2.8B
CNY
|
Other Expenses
|
-1.2B
CNY
|
Net Income
|
1.6B
CNY
|
Free Cash Flow Analysis
Beijing Tongrentang Co Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Beijing Tongrentang Co Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
Beijing Tongrentang Co Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Beijing Tongrentang Co Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Score
Beijing Tongrentang Co Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Beijing Tongrentang Co Ltd
According to Wall Street analysts, the average 1-year price target for Beijing Tongrentang Co Ltd is 50.51 CNY with a low forecast of 30.3 CNY and a high forecast of 63 CNY.
Dividends
Current shareholder yield for Beijing Tongrentang Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Beijing Tong Ren Tang Co., Ltd. engages in the research, production, sale, and distribution of Chinese medicines. The company is headquartered in Beijing, Beijing and currently employs 18,997 full-time employees. The Company’s main products consist of liuwei dihuang series, tongren dahuoluo series, tongren niuhuang qingxin series, angong niuhuang series and donkey-hide gelatin series. The firm distributes its products under the brand of Tongrentang. The firm is also involved in the operation of Tongrentang drug stores. The firm distributes its products in domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Beijing Tongrentang Co Ltd stock under the Base Case scenario is 58.08 CNY.
Compared to the current market price of 39.53 CNY, Beijing Tongrentang Co Ltd is Undervalued by 32%.